Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity

Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID‐19 patients with obesity and chronic diseases such as diabetes and hypertension.

Detalles Bibliográficos
Autores principales: Das, Santa Kumar, Ranabhat, Kamal, Bhattarai, Suraj, Karki, Khem Bahadur, Gyanwali, Pradip, Paneru, Hem Raj, Nepal, Bipin, Dumre, Shyam Prakash, Acharya, Subhash Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013972/
https://www.ncbi.nlm.nih.gov/pubmed/33821192
http://dx.doi.org/10.1002/ccr3.3964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013972/
https://www.ncbi.nlm.nih.gov/pubmed/33821192
http://dx.doi.org/10.1002/ccr3.3964

Ejemplares similares